Close Menu

NEW YORK (GenomeWeb) – Sequenom will collaborate with the University Medical Center Hamburg-Eppendorf in Germany to evaluate the clinical utility of a liquid biopsy assay in colorectal cancer, the firm said today.

Sequenom is currently developing a circulating tumor DNA research assay with an initial focus on the detection and molecular profiling of late stage non-hematologic malignancies in cases where tissues biopsies are not available or are too risky to obtain.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.